A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.

AIM: To examine the safety and efficacy of modafinil (200 mg/day) compared to placebo in the treatment of methamphetamine dependence and to examine predictors of post-treatment outcome. PARTICIPANTS AND DESIGN: Eighty methamphetamine-dependent subjects in Sydney, Australia were allocated randomly to...

Full description

Bibliographic Details

Published in:	Addiction Vol. 104; no. 2; pp. 224 - 234
Main Authors:	Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A
Format:	clinical trial research tables/charts Journal Article
Published:	Wiley-Blackwell Feb2009
Online Access:	View this record in EBSCOhost